Nuvectra™ to Report Fourth Quarter and Full Year 2017 Financial Results on March 6, 2018
February 22, 2018 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the...
Nuvectra Secures $45 Million Second Amendment to Existing Loan and Security Agreement
February 20, 2018 08:30 ET
|
Nuvectra Corporation
PLANO, Texas, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it has reached an agreement with Silicon Valley...
Nuvectra™ Announces Closing of Follow-On Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 05, 2018 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today the closing of its underwritten follow-on public...
Nuvectra™ Announces Pricing of Follow-On Stock Offering
February 01, 2018 09:00 ET
|
Nuvectra Corporation
PLANO, Texas, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public...
Nuvectra™ Announces Proposed Follow-On Stock Offering
January 31, 2018 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it is commencing an underwritten follow-on public...
Nuvectra™ Announces Preliminary Unaudited Fourth Quarter and Full Year 2017 Revenue
January 08, 2018 08:00 ET
|
Nuvectra Corporation
PLANO, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today announced preliminary unaudited revenue for the fourth quarter...
Nuvectra Announces Analyst & Investor Meeting at NANS 2018
January 03, 2018 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that the company will host an Analyst & Investor...
Nuvectra Achieves 1,000th Algovita® SCS System Implantation in U.S.
December 13, 2017 08:01 ET
|
Nuvectra Corporation
PLANO, Texas, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that the company’s Algovita® Spinal Cord Stimulation...
Nuvectra to Present at the 29th Annual Piper Jaffray Healthcare Conference
November 15, 2017 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter...
Nuvectra to Present at the Stifel 2017 Healthcare Conference
November 06, 2017 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter...